Thiopurine Methyltransferase Enzyme Activity Determination before Treatment of Inflammatory Bowel Disease with Azathioprine: Effect on Cost and Adverse Events

Thiopurine Methyltransferase Enzyme Activity Determination before Treatment of Inflammatory Bowel Disease with Azathioprine: Effect on Cost and Adverse Events

BACKGROUND: Azathioprine (AZA), used to treat inflammatory bowel disease (IBD), is metabolized by thiopurine methyltransferase (TPMT). The accumulation of individual metabolites varies because humans display genetic polymorphism for TPMT expression. Deficiencies in TPMT result in accumulation of tox...

Full description

Bibliographic Details
Main Authors:	Farzana A Sayani, Connie Prosser, Robert J Bailey, Philip Jacobs, Richard N Fedorak
Format:	Article
Language:	English
Published:	Hindawi Limited 2005-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2005/470863

Similar Items

The role of polymorphisms of thiopurine methyltransferase in therapy with Azathioprine: preliminary study
by: Francesca Mortillaro, et al.
Published: (2018-11-01)

The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
by: Laura Chisick, et al.
Published: (2013-01-01)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
by: Davide Giuseppe Ribaldone, et al.
Published: (2019-08-01)

Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
by: Ting-Shun Wang, et al.
Published: (2014-03-01)

Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
by: Yue-Ping Liu, et al.
Published: (2015-01-01)

Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
by: Yue-Ping Liu, et al.
Published: (2015-01-01)

Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
by: Katarzyna Bąk-Drabik, et al.
Published: (2021-01-01)

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease
by: Song-Sen Su, et al.
Published: (2020-04-01)

Pharmacogenetic studies of thiopurines : focus on thiopurine methyltransferase
by: Lindqvist Appell, Malin
Published: (2005)

Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis
by: Pathum Sookaromdee, et al.
Published: (2020-01-01)

Thiopurine -methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
by: Polina Zalizko, et al.
Published: (2020-07-01)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
by: Carla J. Gargallo-Puyuelo, et al.
Published: (2021-07-01)

Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.
by: Arno C Hessels, et al.
Published: (2018-01-01)

The role of thiopurine methyltransferase in the metabolism of cytotoxic drugs
by: Coulthard, Sally Anne
Published: (2000)

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
by: Abaji R, et al.
Published: (2017-05-01)

Thiopurine metabolite levels in patients undergoing azathioprine therapy and taking part in the target project
by: Sidgwick, Gary Peter
Published: (2010)

Azathioprine use in inflammatory bowel disease
by: Campbell, Simon Scott
Published: (2003)

Mercaptopurine and inflammatory bowel disease: the other thiopurine
by: Fernando Bermejo, et al.

Optimising thiopurine therapy in inflammatory bowel disease
by: Wong, L. H. J.
Published: (2005)

A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease
by: Fariborz Bahrehmand, et al.
Published: (2017-08-01)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)

Corticosteroids and azathioprine in the treatment of inflammatory bowel disease
by: Powell-Tuck, J.
Published: (1980)

Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values
by: Ayorinde Adehin, et al.
Published: (2018-02-01)

Individualized therapy: Role of thiopurine S-methyltransferase protein and genetic variants
by: Pavlović Sonja, et al.
Published: (2010-01-01)

Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
by: Mehdi Azad, et al.
Published: (2009-01-01)

Screening for thiopurine s-methyltransferase (TPMT) gene mutations in South Africa
by: Olufadi, Rasaq
Published: (2014)

The impact of glutathione S–transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
by: Hui Liu, et al.
Published: (2015-10-01)

Azathioprine in inflammatory bowel disease, a safe alternative?
by: A. A. Tanis
Published: (1998-01-01)

The pharmacogenetics of azathioprine toxicity and efficiency in inflammatory bowel disease
by: Wright, Samantha
Published: (2004)

Optimising the use of Azathioprine in the treatment of Inflammatory Bowel Disease
by: Smith, Melissa Ann
Published: (2016)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
by: Keiichi Tominaga, et al.
Published: (2021-01-01)

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
by: Jack S. Cornish, et al.
Published: (2020-01-01)

Thiopurine S-Methyltransferase Polymorphism in Iraqi Paediatric Patients with Acute Lymphoblastic Leukaemia
by: NAWARS MOHAMMED, et al.
Published: (2019-01-01)

Genotypic and phenotypic analysis of the thiopurine S-methyltransferase (TPMT) gene with clinical correlation
by: Cheung, Siu-ping, et al.
Published: (2014)

Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013)

gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
by: Katsuyoshi Matsuoka
Published: (2020-07-01)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
by: Raphael P. Luber, et al.
Published: (2019-11-01)

Interindividual differences in thiopurine metabolism : studies with focus on inflammatory bowel disease
by: Haglund, Sofie
Published: (2011)

Prescribing trends and the impact of thiopurines on the risk of surgery in inflammatory bowel disease
by: Chhaya, Vivek Haresh
Published: (2016)

Laboratory determination of thiopurine levels in paediatric patients with inflammatory bowel disease
by: Rafael Martín-Masot, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_nalc81ia4lt5ntg4ugn7hdu957